Hologic (HOLX) Competitors $72.50 0.00 (0.00%) (As of 11:57 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends HOLX vs. EW, IDXX, RMD, DXCM, STE, PODD, BAX, GMED, MASI, and TFXShould you be buying Hologic stock or one of its competitors? The main competitors of Hologic include Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), STERIS (STE), Insulet (PODD), Baxter International (BAX), Globus Medical (GMED), Masimo (MASI), and Teleflex (TFX). These companies are all part of the "health care equipment" industry. Hologic vs. Edwards Lifesciences IDEXX Laboratories ResMed DexCom STERIS Insulet Baxter International Globus Medical Masimo Teleflex Hologic (NASDAQ:HOLX) and Edwards Lifesciences (NYSE:EW) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their community ranking, dividends, valuation, media sentiment, earnings, analyst recommendations, institutional ownership, profitability and risk. Do institutionals and insiders hold more shares of HOLX or EW? 94.7% of Hologic shares are owned by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are owned by institutional investors. 1.8% of Hologic shares are owned by insiders. Comparatively, 1.3% of Edwards Lifesciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has more volatility and risk, HOLX or EW? Hologic has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500. Comparatively, Edwards Lifesciences has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500. Does the MarketBeat Community prefer HOLX or EW? Edwards Lifesciences received 458 more outperform votes than Hologic when rated by MarketBeat users. Likewise, 71.03% of users gave Edwards Lifesciences an outperform vote while only 69.63% of users gave Hologic an outperform vote. CompanyUnderperformOutperformHologicOutperform Votes87669.63% Underperform Votes38230.37% Edwards LifesciencesOutperform Votes133471.03% Underperform Votes54428.97% Does the media prefer HOLX or EW? In the previous week, Hologic had 6 more articles in the media than Edwards Lifesciences. MarketBeat recorded 14 mentions for Hologic and 8 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 0.58 beat Hologic's score of 0.48 indicating that Edwards Lifesciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hologic 3 Very Positive mention(s) 6 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Edwards Lifesciences 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Is HOLX or EW more profitable? Edwards Lifesciences has a net margin of 70.82% compared to Hologic's net margin of 19.59%. Edwards Lifesciences' return on equity of 20.76% beat Hologic's return on equity.Company Net Margins Return on Equity Return on Assets Hologic19.59% 19.79% 11.00% Edwards Lifesciences 70.82%20.76%15.27% Do analysts prefer HOLX or EW? Hologic presently has a consensus target price of $89.50, indicating a potential upside of 23.45%. Edwards Lifesciences has a consensus target price of $79.40, indicating a potential upside of 6.11%. Given Hologic's stronger consensus rating and higher possible upside, equities analysts plainly believe Hologic is more favorable than Edwards Lifesciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hologic 0 Sell rating(s) 6 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.67Edwards Lifesciences 0 Sell rating(s) 15 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.42 Which has higher earnings and valuation, HOLX or EW? Edwards Lifesciences has higher revenue and earnings than Hologic. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Hologic, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHologic$4.03B4.08$789.50M$3.3321.77Edwards Lifesciences$6.31B6.99$1.40B$6.9310.80 SummaryEdwards Lifesciences beats Hologic on 12 of the 19 factors compared between the two stocks. Ad WealthPressYour chance to get on the next “60-Second Trade”Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!Just head over here! Get Hologic News Delivered to You Automatically Sign up to receive the latest news and ratings for HOLX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HOLX vs. The Competition Export to ExcelMetricHologicX IndustryMedical SectorNASDAQ ExchangeMarket Cap$16.45B$12.93B$5.23B$9.25BDividend YieldN/A1.91%5.12%4.30%P/E Ratio21.7721.7587.6217.25Price / Sales4.0810.781,167.09120.47Price / Cash13.7312.7743.2337.83Price / Book3.282.564.824.92Net Income$789.50M$273.70M$120.46M$225.43M7 Day Performance0.33%19.84%-0.57%0.74%1 Month Performance-8.19%10.60%15.69%2.37%1 Year Performance2.06%29.42%29.92%16.58% Hologic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HOLXHologic4.6731 of 5 stars$72.50flat$89.50+23.4%+2.1%$16.45B$4.03B21.777,063EWEdwards Lifesciences3.8769 of 5 stars$74.45-0.5%$79.40+6.6%-1.3%$43.91B$6.31B10.7419,800IDXXIDEXX Laboratories4.9697 of 5 stars$409.21-0.7%$539.63+31.9%-25.4%$33.51B$3.84B39.4611,000RMDResMed4.4665 of 5 stars$228.17-3.8%$227.91-0.1%+34.9%$33.49B$4.81B30.229,980DXCMDexCom4.9159 of 5 stars$79.05-1.2%$98.00+24.0%-34.9%$30.88B$3.95B47.349,600STESTERIS4.9387 of 5 stars$207.03-0.2%$262.50+26.8%-5.4%$20.44B$5.33B47.2718,179Positive NewsPODDInsulet4.1176 of 5 stars$261.37-2.0%$269.40+3.1%+21.8%$18.33B$1.98B44.763,000BAXBaxter International4.5291 of 5 stars$29.01-1.7%$40.45+39.5%-24.0%$14.81B$15.06B145.0660,000GMEDGlobus Medical4.8598 of 5 stars$83.01+0.5%$94.55+13.9%+54.8%$11.30B$2.48B123.905,000MASIMasimo3.5889 of 5 stars$166.79-1.6%$175.67+5.3%+41.9%$8.93B$2.05B115.035,200TFXTeleflex4.8657 of 5 stars$176.92-0.7%$252.50+42.7%-29.0%$8.22B$3.03B35.1714,500 Related Companies and Tools Related Companies Edwards Lifesciences Alternatives IDEXX Laboratories Alternatives ResMed Alternatives DexCom Alternatives STERIS Alternatives Insulet Alternatives Baxter International Alternatives Globus Medical Alternatives Masimo Alternatives Teleflex Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HOLX) was last updated on 12/24/2024 by MarketBeat.com Staff From Our Partners"This looks and feels like 2000," says investing legendOur senior analyst Dan Ferris says a new surprise crisis could begin at any moment... and this time, he says i...Stansberry Research | SponsoredA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading syst...Prosper Trading Academy | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredWall St. Icon: “If you wait on this, it will already be too late”If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hologic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hologic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HOLX Stock Alerts